EKF Diagnostics (LON:EKF – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX 0.54 EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%.
EKF Diagnostics Trading Down 2.3%
EKF traded down GBX 0.60 during mid-day trading on Wednesday, reaching GBX 25. The stock had a trading volume of 191,987 shares, compared to its average volume of 326,429. The firm’s fifty day simple moving average is GBX 25.45 and its two-hundred day simple moving average is GBX 25.51. The stock has a market capitalization of £107.04 million, a P/E ratio of 53.19 and a beta of 0.50. EKF Diagnostics has a 52 week low of GBX 22 and a 52 week high of GBX 31.70. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
- Five stocks we like better than EKF Diagnostics
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
